Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPFinancial_Report.xls
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR9.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR2.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR1.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR4.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR3.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR5.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR8.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR6.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR22.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR23.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR13.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR24.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR17.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR11.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR19.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR15.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR27.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR12.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR14.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR25.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR16.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR26.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR10.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR18.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR20.htm
EX-10.1 - EXHIBIT 10.1 - HEALTH DISCOVERY CORPex10-1.htm
EX-32.1 - EXHIBIT 32.1 - HEALTH DISCOVERY CORPex32-1.htm
EX-10.2 - EXHIBIT 10.2 - HEALTH DISCOVERY CORPex10-2.htm
EX-31.1 - EXHIBIT 31.1 - HEALTH DISCOVERY CORPex31-1.htm
10-Q - FORM 10-Q - HEALTH DISCOVERY CORPt74989_10q.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR21.htm
v2.4.0.6
REVENUE RECOGNITION
9 Months Ended
Sep. 30, 2012
Deferred Revenue Disclosure [Abstract]  
REVENUE RECOGNITION
Note B – REVENUE RECOGNITION
 
Revenue is generated through the sale or license of patented technology and processes and from services provided through development agreements. These arrangements are generally governed by contracts that dictate responsibilities and payment terms. The Company recognizes revenues as they are earned over the duration of a license agreement or upon the sale of any owned patent once all contractual obligations have been fulfilled. If a license agreement has an undetermined or unlimited life, the revenue is recognized over the remaining expected life of the patents. Revenue is recognized under development agreements in the period the services are performed.
 
The Company treats the incremental direct cost of revenue arrangements, which consists principally of employee bonuses, as deferred charges and these incremental direct costs are amortized to expense using the straight-line method over the same term as the related deferred revenue recognition.
 
The licensing and development revenue recognized during the three and nine month periods ended September 30, 2012 includes $457,088 related to the acceleration of the revenue recognition from deferred revenue because of the termination of the Abbott and Quest contracts.
 
Deferred revenue represents the unearned portion of payments received in advance for licensing and development agreements. The Company had total unearned revenue of $2,497,851 as of September 30, 2012. Unearned revenue of $1,024,988 is recorded as current and $1,472,863is classified as long-term.